Cornerstone Pharmaceuticals Overview
- Year Founded
-
2000
- Status
-
Private
- Employees
-
19
- Latest Deal Type
-
PIPE
- (Cancelled)
- Latest Deal Amount
-
$50M
- Investors
-
7
Cornerstone Pharmaceuticals General Information
Description
Developer of metabolic oncology therapeutics designed to treat cancer patients. The company's therapeutics apply bio-energetic processes specific to cancer and provide altered cancer metabolism-directed therapies and novel, drugs and drug delivery technologies, enabling patients to avail of safe cancer treatments and oncology professionals to improve the safety and efficacy of cancer treatments, with minimal toxicity to healthy cells.
Contact Information
Website
www.cornerstonepharma.comCorporate Office
- 1 Duncan Drive
- Cranbury, NJ 08512
- United States
Corporate Office
- 1 Duncan Drive
- Cranbury, NJ 08512
- United States
Cornerstone Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 13. PIPE | 21-Jun-2021 | $50M | Cancelled | Clinical Trials - Phase 2 | ||
| 12. Reverse Merger | 21-Jun-2021 | Cancelled | Clinical Trials - Phase 2 | |||
| 11. Later Stage VC (Series C) | Completed | Clinical Trials - Phase 2 | ||||
| 10. Secondary Transaction - Private | 02-Mar-2017 | Completed | Clinical Trials - Phase 2 | |||
| 9. Later Stage VC | 10-Nov-2016 | Completed | Clinical Trials - Phase 2 | |||
| 8. Grant | 21-Jan-2015 | Completed | Clinical Trials - Phase 2 | |||
| 7. Later Stage VC (Series B) | 29-Jan-2010 | Completed | Clinical Trials - Phase 2 | |||
| 6. Later Stage VC (Series A) | 27-May-2009 | Completed | Clinical Trials - Phase 2 | |||
| 5. Secondary Transaction - Open Market | 01-Feb-2008 | $19.7M | Cancelled | Clinical Trials - Phase 2 | ||
| 4. Later Stage VC | 23-Feb-2006 | $1M | $6.51M | Completed | Clinical Trials - Phase 2 |
Cornerstone Pharmaceuticals Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
Cornerstone Pharmaceuticals Comparisons
Industry
Financing
Details
Cornerstone Pharmaceuticals Competitors (109)
One of Cornerstone Pharmaceuticals’s 109 competitors is Spark Therapeutics, a Formerly VC-backed company based in Philadelphia, PA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Spark Therapeutics | Formerly VC-backed | Philadelphia, PA | ||||
| Aro Biotherapeutics | Venture Capital-Backed | Philadelphia, PA | ||||
| AnTolRx | Formerly VC-backed | Cambridge, MA | ||||
| Immunitas Therapeutics | Formerly VC-backed | Boston, MA | ||||
| Ability Pharma | Private Equity-Backed | Cerdanyola, Spain |
Cornerstone Pharmaceuticals Signals
Cornerstone Pharmaceuticals Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Angel (individual) | Minority | |||
| IDT (Newark) | Holding Company | Minority | ||
| New Jersey Economic Development Authority | Government | |||
| Althea Partners | Venture Capital | Minority | ||
| Angel (individual) | Minority |
Cornerstone Pharmaceuticals FAQs
-
When was Cornerstone Pharmaceuticals founded?
Cornerstone Pharmaceuticals was founded in 2000.
-
Where is Cornerstone Pharmaceuticals headquartered?
Cornerstone Pharmaceuticals is headquartered in Cranbury, NJ.
-
What is the size of Cornerstone Pharmaceuticals?
Cornerstone Pharmaceuticals has 19 total employees.
-
What industry is Cornerstone Pharmaceuticals in?
Cornerstone Pharmaceuticals’s primary industry is Drug Discovery.
-
Is Cornerstone Pharmaceuticals a private or public company?
Cornerstone Pharmaceuticals is a Private company.
-
What is Cornerstone Pharmaceuticals’s current revenue?
The current revenue for Cornerstone Pharmaceuticals is .
-
How much funding has Cornerstone Pharmaceuticals raised over time?
Cornerstone Pharmaceuticals has raised $29.2M.
-
Who are Cornerstone Pharmaceuticals’s investors?
, IDT (Newark), New Jersey Economic Development Authority, Althea Partners, and are 5 of 7 investors who have invested in Cornerstone Pharmaceuticals.
-
Who are Cornerstone Pharmaceuticals’s competitors?
Spark Therapeutics, Aro Biotherapeutics, AnTolRx, Immunitas Therapeutics, and Ability Pharma are some of the 109 competitors of Cornerstone Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process